Aplindore

Aplindore

SCHEMBL3029385

Cc1ccc(S(=O)(=O)O)cc1.O=C1Cc2c(ccc3c2O[C@@H](CNCc2ccccc2)CO3)N1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DRD2

The experimentally established mechanism targets of Aplindore. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DRD2 known ✓ P14416 8/20 0.54
DRD4 P21917 4/20 0.54
DRD3 P35462 4/20 0.54
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
LMNA P02545 2/20 0.41
ALDH1A1 P00352 1/20 0.39
SLC6A4 P31645 3/20 0.39
HTR2A P28223 2/20 0.39
HTR2B P41595 2/20 0.39
HTR6 P50406 1/20 0.38
HTR1A P08908 1/20 0.37
HTR2C P28335 1/20 0.37
PARP1 P09874 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5957139 0.88 DRD2 (0.55) DRD2DRD4DRD3KMT2AMEN1
Aplindore SCHEMBL29359212 0.88 DRD2 (0.68) DRD2DRD4DRD3KMT2AMEN1
Aplindore SCHEMBL119499 0.88 DRD2 (0.68) DRD2DRD4DRD3KMT2AMEN1
Aplindore SCHEMBL3192098 0.88 DRD2 (0.68) DRD2DRD4DRD3KMT2AMEN1
Aplindore SCHEMBL29470967 0.84 DRD2 (0.60) DRD2DRD4DRD3KMT2AMEN1
Aplindore SCHEMBL1231153 0.84 DRD2 (0.60) DRD2DRD4DRD3KMT2AMEN1
Aplindore SCHEMBL5954695 0.84 DRD2 (0.60) DRD2DRD4DRD3KMT2AMEN1
SCHEMBL7395323 0.82 DRD2 (0.45) DRD2DRD4DRD3KMT2AMEN1
SCHEMBL7397482 0.81 DRD2 (0.44) DRD2DRD4DRD3KMT2AMEN1
SCHEMBL5957109 0.80 DRD2 (0.58) DRD2DRD4DRD3KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8466296-B2 Compounds and processes for preparing substituted aminomethyl-2,3,8,9-tetrahydro-7H-1,4-dioxino[2,3-e]indol-8-ones LIGAND PHARMACEUTICALS (US) 2013-06-18 US disclosed
US-20100217012-A1 COMPOUNDS AND PROCESSES FOR PREPARING SUBSTITUTED AMINOMETHYL-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e]INDOL-8-ONES NEUROGEN CORPORATION (US) 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100217012-A1 COMPOUNDS AND PROCESSES FOR PREPARING SUBSTITUTED AMINOMETHYL-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e]INDOL-8-ONES MTNR1A, HTR3C, MTNR1B DRD2 27/4885DRD4 59/4885DRD3 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.